# Safety and Efficacy of Intermittent Renal Replacement Therapy Using CITRASATE in Critically-ill Patients

> **NCT05313230** · — · UNKNOWN · sponsor: **University Hospital, Montpellier** · enrollment: 61 (estimated)

## Conditions studied

- Acute Kidney Injury
- Chronic Kidney Infection

## Interventions

- **OTHER:** CITRASATE SLED

## Key facts

- **NCT ID:** NCT05313230
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-02-01
- **Primary completion:** 2022-06-01
- **Final completion:** 2022-06-30
- **Target enrollment:** 61 (ESTIMATED)
- **Last updated:** 2022-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05313230

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05313230, "Safety and Efficacy of Intermittent Renal Replacement Therapy Using CITRASATE in Critically-ill Patients". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT05313230. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*